UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

BNT162b vaccines protect rhesus macaques from SARS-CoV-2

Nature (London), 2021-04, Vol.592 (7853), p.283-289

2021

Volltextzugriff (PDF)

mRNA vaccine for cancer immunotherapy

Molecular cancer, 2021-02, Vol.20 (1), p.41-41, Article 41

2021

Volltextzugriff (PDF)

Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2

Nature (London), 2021-08, Vol.596 (7872), p.417-422

2021

Volltextzugriff (PDF)

Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice

Nature communications, 2021-05, Vol.12 (1), p.2893-2893, Article 2893

2021

Volltextzugriff (PDF)

Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study

Nature medicine, 2021-06, Vol.27 (6), p.1062-1070

2021

Volltextzugriff (PDF)

CureVac COVID vaccine let-down spotlights mRNA design challenges

Nature (London), 2021-06, Vol.594 (7864), p.483-483

Dolgin, Elie

2021

Volltextzugriff (PDF)

Dengue vaccine: hypotheses to understand CYD-TDV-induced protection

Nature reviews. Microbiology, 2016-01, Vol.14 (1), p.45-54

2016

Volltextzugriff (PDF)

How COVID unlocked the power of RNA vaccines

Nature (London), 2021-01, Vol.589 (7841), p.189-191

Dolgin, Elie

2021

Volltextzugriff (PDF)

An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques

Nature communications, 2020-08, Vol.11 (1), p.4207-4207, Article 4207

2020

Volltextzugriff (PDF)

A vaccine-based nanosystem for initiating innate immunity and improving tumor immunotherapy

Nature communications, 2020-04, Vol.11 (1), p.1985-15, Article 1985

2020

Volltextzugriff (PDF)

Could mixing COVID vaccines boost immune response?

Nature (London), 2021-02, Vol.590 (7846), p.375-376

Ledford, Heidi

2021

Volltextzugriff (PDF)

Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials

Nature communications, 2024-05, Vol.15 (1), p.4081-13, Article 4081

2024

Volltextzugriff (PDF)

S1 domain of the porcine epidemic diarrhea virus spike protein as a vaccine antigen

Virology journal, 2016-04, Vol.13 (57), p.57-57, Article 57

2016

Volltextzugriff (PDF)

Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with multiple myeloma

BMC cancer, 2021-12, Vol.21 (1), p.1354-5, Article 1354

2021

Volltextzugriff (PDF)

The biological function of antibodies induced by the RTS,S/AS01 malaria vaccine candidate is determined by their fine specificity

Malaria journal, 2016-05, Vol.15 (1), p.301-301, Article 301

2016

Volltextzugriff (PDF)

Bacterial superglue generates a full-length circumsporozoite protein virus-like particle vaccine capable of inducing high and durable antibody responses

Malaria journal, 2016-11, Vol.15 (1), p.545-545, Article 545

2016

Volltextzugriff (PDF)

Serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with SARS-CoV-2 spike protein messenger RNA (mRNA) vaccines

Leukemia, 2021-12, Vol.35 (12), p.3578-3580

2021

Volltextzugriff (PDF)

Single dose of chimeric dengue-2/Zika vaccine candidate protects mice and non-human primates against Zika virus

Nature communications, 2021-12, Vol.12 (1), p.7320-7320, Article 7320

2021

Volltextzugriff (PDF)

Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates

Malaria journal, 2016-08, Vol.15 (1), p.405-405, Article 405

2016

Volltextzugriff (PDF)

Cross-serotype protection against group A Streptococcal infections induced by immunization with SPy_2191

Nature communications, 2020-07, Vol.11 (1), p.3545-3545, Article 3545

2020

Volltextzugriff (PDF)

The potential use of therapeutics and prophylactic mRNA vaccines in human papillomavirus (HPV)

Virology journal, 2024-05, Vol.21 (1), p.124-20, Article 124

2024

Volltextzugriff (PDF)

Multivalent display of minimal Clostridium difficile glycan epitopes mimics antigenic properties of larger glycans

Nature communications, 2016-04, Vol.7 (1), p.11224-11224, Article 11224

2016

Volltextzugriff (PDF)

Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 months

Virology journal, 2013-07, Vol.10 (1), p.237-237, Article 237

2013

Volltextzugriff (PDF)

1 – 25 von 116

Suche als RSS-Feed

Aktive Filter

KollektionNexis Uni

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(116)
Mit Volltextzugriff
(96)

Publikationsform

Artikel
(116)

Sprache

Englisch
(116)

Erscheinungsjahr

n.n

Thema

Science & Technology
(109)
Vaccines, Synthetic - Administration & Dosage
(95)
Life Sciences & Biomedicine
(93)
Vaccines, Synthetic - Immunology
(93)
Animals
(91)
Vaccines
(75)
Humans
(53)
Mice
(51)
Female
(48)
Virology
(46)
Vaccines, Synthetic - Genetics
(45)
Health Aspects
(40)
Immune Response
(39)
Immunization
(33)
Proteins
(33)
Antibodies, Viral - Blood
(31)
Vaccination
(31)
Antibodies
(30)
Viruses
(30)
Mice, Inbred Balb C
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Virology Journal
(43)
Malaria Journal
(18)
Nature
(12)
Nature Biotechnology
(8)
Nature Communications
(8)
Nature Medicine
(8)
Bio/technology
(3)
Cancer Gene Therapy
(3)
The Medical Letter On Drugs And Therapeutics
(3)
Nature Reviews. Microbiology
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

BNT162b vaccines protect rhesus macaques from SARS-CoV-2

mRNA vaccine for cancer immunotherapy

Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice

Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA vaccine in younger and older Chinese adults: a randomized, placebo-controlled, double-blind phase 1 study

CureVac COVID vaccine let-down spotlights mRNA design challenges

Dengue vaccine: hypotheses to understand CYD-TDV-induced protection

How COVID unlocked the power of RNA vaccines

A multiclade env-gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques

An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques

A vaccine-based nanosystem for initiating innate immunity and improving tumor immunotherapy

Could mixing COVID vaccines boost immune response?

Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials

S1 domain of the porcine epidemic diarrhea virus spike protein as a vaccine antigen

Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with multiple myeloma

The biological function of antibodies induced by the RTS,S/AS01 malaria vaccine candidate is determined by their fine specificity

Bacterial superglue generates a full-length circumsporozoite protein virus-like particle vaccine capable of inducing high and durable antibody responses

Serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with SARS-CoV-2 spike protein messenger RNA (mRNA) vaccines

Single dose of chimeric dengue-2/Zika vaccine candidate protects mice and non-human primates against Zika virus

Assessment of Pfs25 expressed from multiple soluble expression platforms for use as transmission-blocking vaccine candidates

Cross-serotype protection against group A Streptococcal infections induced by immunization with SPy_2191

The potential use of therapeutics and prophylactic mRNA vaccines in human papillomavirus (HPV)

Multivalent display of minimal Clostridium difficile glycan epitopes mimics antigenic properties of larger glycans

Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 months

Aktive Filter

Suchergebnisse filtern